These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 37766264)
1. Lichen or Associated Micro-Organism Compounds Are Active against Human Coronaviruses. Desmarets L; Millot M; Chollet-Krugler M; Boustie J; Camuzet C; François N; Rouillé Y; Belouzard S; Tomasi S; Mambu L; Séron K Viruses; 2023 Aug; 15(9):. PubMed ID: 37766264 [TBL] [Abstract][Full Text] [Related]
3. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway. Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913 [TBL] [Abstract][Full Text] [Related]
4. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action. Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232 [TBL] [Abstract][Full Text] [Related]
5. Assessment of Antiviral Coatings for High-Touch Surfaces by Using Human Coronaviruses HCoV-229E and SARS-CoV-2. Butot S; Baert L; Zuber S Appl Environ Microbiol; 2021 Sep; 87(19):e0109821. PubMed ID: 34288707 [TBL] [Abstract][Full Text] [Related]
6. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses. Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775 [TBL] [Abstract][Full Text] [Related]
7. Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold. Gudmundsdottir Á; Scheving R; Lindberg F; Stefansson B J Med Virol; 2021 Mar; 93(3):1792-1795. PubMed ID: 32975843 [TBL] [Abstract][Full Text] [Related]
8. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan. Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267 [TBL] [Abstract][Full Text] [Related]
9. Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E). Parang K; El-Sayed NS; Kazeminy AJ; Tiwari RK Molecules; 2020 May; 25(10):. PubMed ID: 32429580 [TBL] [Abstract][Full Text] [Related]
10. More tools for our toolkit: The application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitro. Semple SL; Alkie TN; Jenik K; Warner BM; Tailor N; Kobasa D; DeWitte-Orr SJ Virus Res; 2022 Nov; 321():198925. PubMed ID: 36115551 [TBL] [Abstract][Full Text] [Related]
11. Discovery of Anti-Coronavirus Cinnamoyl Triterpenoids Isolated from Al Ibrahim M; Akissi ZLE; Desmarets L; Lefèvre G; Samaillie J; Raczkiewicz I; Sahpaz S; Dubuisson J; Belouzard S; Rivière C; Séron K Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068938 [TBL] [Abstract][Full Text] [Related]
12. Cytopathic Effect Assay and Plaque Assay to Evaluate Hu Y; Ma C; Wang J Bio Protoc; 2022 Feb; 12(3):e4314. PubMed ID: 35284599 [TBL] [Abstract][Full Text] [Related]
13. Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2. Liu D; Chen C; Chen D; Zhu A; Li F; Zhuang Z; Mok CKP; Dai J; Li X; Jin Y; Chen Z; Sun J; Wang Y; Li Y; Zhang Y; Wen L; Zhang Z; Zhuo J; Wang J; Ran W; Wang D; Zhang S; Tang Y; Li S; Lai X; Wei P; Yuan J; Chen F; Huang S; Sun F; Qian Z; Tan W; Zhao J; Peiris M; Zhao J Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2202820120. PubMed ID: 36652473 [TBL] [Abstract][Full Text] [Related]
14. Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell. Hu Y; Jo H; DeGrado WF; Wang J J Med Virol; 2022 May; 94(5):2188-2200. PubMed ID: 35080027 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system. Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702 [TBL] [Abstract][Full Text] [Related]
16. AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 Good SS; Westover J; Jung KH; Zhou XJ; Moussa A; La Colla P; Collu G; Canard B; Sommadossi JP Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558299 [TBL] [Abstract][Full Text] [Related]
17. Antibacterial and anti-coronavirus investigation of selected Senegalese plant species according to an ethnobotanical survey. Ba A; Roumy V; Al Ibrahim M; Raczkiewicz I; Samaillie J; Hakem A; Sahpaz S; Belouzard S; Diatta W; Sidybé M; Neut C; Séron K; Seck M; Rivière C J Ethnopharmacol; 2024 Jun; 328():118070. PubMed ID: 38521430 [TBL] [Abstract][Full Text] [Related]
18. Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E Genogroup. Lau SKP; Lung DC; Wong EYM; Aw-Yong KL; Wong ACP; Luk HKH; Li KSM; Fung J; Chan TTY; Tang JYM; Zhu L; Yip CCY; Wong SCY; Lee RA; Tsang OTY; Yuen KY; Woo PCY mSphere; 2021 Feb; 6(1):. PubMed ID: 33568452 [TBL] [Abstract][Full Text] [Related]
19. An overview on the seven pathogenic human coronaviruses. Kesheh MM; Hosseini P; Soltani S; Zandi M Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073 [TBL] [Abstract][Full Text] [Related]
20. Development and efficacy assessment of hand sanitizers and polylactic acid films incorporating caffeic acid and vanillin for enhanced antiviral properties against HCoV-229E. Hyun SW; Han S; Son JW; Song MS; Kim DA; Ha SD Virol J; 2023 Aug; 20(1):194. PubMed ID: 37641064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]